Igc Pharma Inc (IGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,583 | 1,470 | 388 | 602 | 843 |
| Receivables | 3,312 | 8,600 | 9,153 | 8,660 | 7,898 |
| Inventories | 134 | 332 | 213 | 185 | 162 |
| Income taxes - deferred | N/A | N/A | N/A | 562 | 25 |
| Other current assets | 42 | 42 | 42 | 41 | 120 |
| TOTAL | $6,545 | $11,620 | $11,430 | $10,892 | $11,103 |
| Non-Current Assets | |||||
| PPE Net | 1,232 | 1,456 | 1,562 | 1,598 | 1,748 |
| Investments And Advances | 7,307 | 9,525 | 9,436 | 9,391 | 9,254 |
| Intangibles | 411 | 6,167 | 6,201 | 5,953 | 6,147 |
| Other Non-Current Assets | 2,668 | 8,182 | 8,204 | 6,940 | 7,118 |
| TOTAL | $11,617 | $25,330 | $25,402 | $23,883 | $24,267 |
| Total Assets | $18,162 | $36,950 | $36,831 | $34,774 | $35,370 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 901 | 1,416 | 1,001 | 973 | 1,389 |
| Accounts payable and accrued liabilities | 1,312 | 3,683 | 0 | 1,584 | 1,989 |
| Accrued Expenses | 349 | 128 | 417 | 409 | 461 |
| Other current liabilities | 95 | 63 | 474 | 363 | 150 |
| TOTAL | $6,577 | $9,210 | $9,451 | $7,449 | $8,109 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 5,050 | 3,318 | 1,122 | 1,146 | 1,199 |
| TOTAL | $4,292 | $3,305 | $1,125 | $1,146 | $1,108 |
| Total Liabilities | $10,869 | $12,515 | $10,576 | $8,596 | $9,216 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,976 | 1,713 | 1,365 | 1,339 | 1,334 |
| Common Shares | 2 | 1 | 1 | 1 | 1 |
| Retained earnings | -29,693 | -12,649 | -10,899 | -10,043 | -9,452 |
| Other shareholders' equity | -1,876 | -1,178 | -1,096 | -1,596 | -1,202 |
| TOTAL | $7,293 | $24,435 | $26,256 | $26,178 | $26,154 |
| Total Liabilities And Equity | $18,162 | $36,950 | $36,831 | $34,774 | $35,370 |